REVIEW
Add like
Add dislike
Add to saved papers

Trichinellosis in China: epidemiology and control.

The first outbreak of human trichinellosis in China, according to official national publication, was registered in Tibet in 1964. Since then, more than 500 outbreaks, numbering 25161 cases with 240 deaths, have been recorded. However, this reported quantity is probably highly underestimated because adequate diagnostic techniques might not have been available in the whole area. Moreover, infection in animals is widespread over China, with the prevalence of pig trichinellosis being as high as 4% in some provinces. The estimated situation of trichinellosis in China highlights the necessity not only for its control, but also for the government to elaborate new regulations and guidelines for animal inspection.

Full text links

Management of Latent Tuberculosis Infection.JAMA 2023 January 20
Misdiagnosis in the Emergency Department: Time for a System Solution.JAMA 2023 January 28

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app